A structure-based algorithm to predict potential binding peptides to MHC molecules with hydrophobic binding pockets

Human Immunology

Volumn 58, Issue 1, 1997, Pages 1-11

  Altuvia, Yael ^a   Sette, Alessandro ^b   Sidney, John ^b   Southwood, Scott ^b   Margalit, Hanah ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b CYTEL CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN;

ALGORITHM; AMINO ACID SEQUENCE; ANIMAL CELL; ANTIGENICITY; ARTICLE; BINDING AFFINITY; CYTOTOXIC T LYMPHOCYTE; HYDROPHOBICITY; IMMUNE RESPONSE; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; T LYMPHOCYTE ACTIVATION;

ALGORITHMS; ANIMALS; ANTIGEN PRESENTATION; COMPUTER SIMULATION; H-2 ANTIGENS; HLA-A ANTIGENS; HLA-A2 ANTIGEN; HLA-B27 ANTIGEN; HUMANS; PEPTIDES; PREDICTIVE VALUE OF TESTS;

EID: 0031455540     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(97)00210-3     Document Type: Article

References (52)

1. Townsend A, Bodmer H. Antigen recognition by class I-restricted T lymphocytes. Annu Rev Immunol. 7:1989;601.
2. Barber LD, Parham P. The essence of epitopes. J Exp Med. 180:1994;1191.
3. Walden P. T-cell epitope determination. Curr Opin Immunol. 8:1996;68.
4. Chen W, Khilko S, Fecondo J, Margulies DH, McCluskey J. Determinant selection of major histocompatibility complex class I-restricted antigenic peptides is explained by class I-peptide affinity and is strongly influenced by nondominant anchor residues. J Exp Med. 180:1994;1471.
5. Ressing ME, Sette A, Brandt RM, Ruppert J, Wentworth PA, Hartman M, Oseroff C, Grey HM, Melief CJ, Kast WM. Human CTL epitopes encoded by human papillomavirus type 16 E6 and E7 identified through in vivo and in vitro immunogenicity studies of HLA-A*0201-binding peptides. J Immunol. 154:1995;5934.
6. Elliott T, Smith M, Driscoll P, McMichael A. Peptide selection by class I molecules of the major histocompatibility complex. Current Biology. 3:1993;854.
7. Engelhard VH. Structure of peptides associated with class I and class II MHC molecules. Annu Rev Immunol. 12:1994;181.
8. Stern LJ, Wiley DC. Antigenic peptide binding by class I and class II histocompatibility proteins. Structure. 2:1994;245.
9. Madden DR. The three-dimensional structure of peptide-MHC complexes. Annu Rev Immunol. 13:1995;587.
10. Rammensee HG, Friede T, Stevanoviic S. MHC ligands and peptide motifs first listing . Immunogenetics. 41:1995;178.
11. Pamer EG, Harty JT, Bevan MJ. Precise prediction of a dominant class I MHC-restricted epitope of Listeria monocytogenes [see comments]. Nature. 353:1991;852.
12. Meister GE, Roberts CG, Berzofsky JA, De Groot AS. Two novel T cell epitope prediction algorithms based on MHC-binding motifs; comparison of predicted and published epitopes from Mycobacterium tuberculosis and HIV protein sequences. Vaccine. 13:1995;581.
13. Jameson SC, Bevan MJ. Dissection of major histocompatibility complex (MHC) and T cell receptor contact residues in a Kb-restricted ovalbumin peptide and an assessment of the predictive power of MHC-binding motifs. Eur J Immunol. 22:1992;2663.
14. Ruppert J, Sidney J, Celis E, Kubo RT, Grey HM, Sette A. Prominent role of secondary anchor residues in peptide binding to HLA-A2 1 molecules . Cell. 74:1993;929.
15. Kast WM, Brandt RM, Sidney J, Drijfhout JW, Kubo RT, Grey HM, Melief CJ, Sette A. Role of HLA-A motifs in identification of potential CTL epitopes in human papillomavirus type 16 E6 and E7 proteins. J Immunol. 152:1994;3904.
16. Kondo A, Sidney J, Southwood S, del Guercio MF, Appella E, Sakamoto H, Celis E, Grey HM, Chesnut RW, Kubo RT, et al. Prominent roles of secondary anchor residues in peptide binding to HLA-A24 human class I molecules. J Immunol. 155:1995;4307.
17. Sigal LJ, Goebel P, Wylie DE. Db-binding peptides from influenza virus effect of non-anchor residues on stability and immunodominance . Mol Immunol. 32:1995;623.
18. Hammer J, Bono E, Gallazzi F, Belunis C, Nagy Z, Sinigaglia F. Precise prediction of major histocompatibility complex class II-peptide interaction based on peptide side chain scanning. J Exp Med. 180:1994;2353.
19. Parker KC, Bednarek MA, Coligan JE. Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. J Immunol. 152:1994;163.
20. D'Amaro J, Houbiers JG, Drijfhout JW, Brandt RM, Schipper R, Bavinck JN, Melief CJ, Kast WM. A computer program for predicting possible cytotoxic T lymphocyte epitopes based on HLA class I peptide-binding motifs. Hum Immunol. 43:1995;13.
21. Marshall KW, Wilson KJ, Liang J, Woods A, Zaller D, Rothbard JB. Prediction of peptide affinity to HLA DRB1*0401. Journal of Immunology. 154:1995;5927.
22. Jones DT, Thornton JM. Potential energy functions for threading. Curr Opin Struct Biol. 6:1996;210.
23. Madden DR, Garboczi DN, Wiley DC. The antigenic identity of peptide-MHC complexes a comparison of the conformations of five viral peptides presented by HLA-A2 [published erratum appears in Cell 1994 Jan 28;76(2):following 410] . Cell. 75:1993;693.
24. Altuvia Y, Schueler O, Margalit H. Ranking potential binding peptides to MHC molecules by a computational threading approach. J Mol Biol. 249:1995;244.
25. Miyazawa S, Jernigan RL. Estimation of effective inter-residue contact energies from protein crystal structures, quasi-chemical approximation. Macromolecules. 18:1985;534.
26. Miyazawa S, Jernigan RL. Residue-residue potentials with a favorable contact pair term and an unfavorable high packing density term, for simulation and threading. J Mol Biol. 256:1996;623.
27. Silver ML, Guo HC, Strominger JL, Wiley DC. Atomic structure of a human MHC molecule presenting an influenza virus peptide [see comments]. Nature. 360:1992;367.
28. Madden DR, Gorga JC, Strominger JL, Wiley DC. The three-dimensional structure of HLA-B27 at 2 1 A resolution suggests a general mechanism for tight peptide binding to MHC . Cell. 70:1992;1035.
29. Koenig S, Woods RM, Brewah YA, Newell AJ, Jones GM, Boone E, Adelsberger JW, Baseler MW, Robinson SM, Jacobson S. Characterization of MHC class I restricted cytotoxic T cell responses to tax in HTLV-1 infected patients with neurologic disease. J Immunol. 151:1993;3874.
30. Godzik A, Kolinski A, Skolnick J. Are proteins ideal mixtures of amino acids? Analysis of energy parameter sets . Protein Sci. 4:1995;2107.
31. Fremont DH, Matsumura M, Stura EA, Peterson PA, Wilson IA. Crystal structures of two viral peptides in complex with murine MHC class I H-2Kb [see comments]. Science. 257:1992;919.
32. Fremont DH, Stura EA, Matsumura M, Peterson PA, Wilson IA. Crystal structure of an H-2Kb-ovalbumin peptide complex reveals the interplay of primary and secondary anchor positions in the major histocompatibility complex binding groove. Proc Natl Acad Sci U S A. 92:1995;2479.
33. Wolfel T, Van Pel A, Brichard V, Schneider J, Seliger B, Meyer zum Buschenfelde KH Boon T. Two tyrosinase nonapeptides recognized on HLA-A2 melanomas by autologous cytolytic T lymphocytes. Eur J Immunol. 24:1994;759.
34. Tarpey I, Stacey S, Hickling J, Birley HD, Renton A, McIndoe A, Davies DH. Human cytotoxic T lymphocytes stimulated by endogenously processed human papillomavirus type 11 E7 recognize a peptide containing a HLA-A2 (A*0201) motif. Immunology. 81:1994;222.
35. Lee SP, Thomas WA, Murray RJ, Khanim F, Kaur S, Young LS, Rowe M, Kurilla M, Rickinson AB. HLA A2 1-restricted cytotoxic T cells recognizing a range of Epstein-Barr virus isolates through a defined epitope in latent membrane protein LMP2 . J Virol. 67:1993;7428.
36. Nayersina R, Fowler P, Guilhot S, Missale G, Cerny A, Schlicht HJ, Vitiello A, Chesnut R, Person JL, Redeker AG, et al. HLA A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection. J Immunol. 150:1993;4659.
37. Gotch F, Rothbard J, Howland K, Townsend A, McMichael A. Cytotoxic T lymphocytes recognize a fragment of influenza virus matrix protein in association with HLA-A2. Nature. 326:1987;881.
38. Walker BD, Flexner C, Birch Limberger K Fisher L, Paradis TJ, Aldovini A, Young R, Moss B, Schooley RT. Long-term culture and fine specificity of human cytotoxic T-lymphocyte clones reactive with human immunodeficiency virus type. Proc Natl Acad Sci U S A. 86:1989;9514.
39. Tsomides TJ, Walker BD, Eisen HN. An optimal viral peptide recognized by CD8 + T cells binds very tightly to the restricting class I major histocompatibility complex protein on intact cells but not to the purified class I protein. Proc Natl Acad Sci U S A. 88:1991;11276.
40. Dadaglio G, Leroux A, Langlade Demoyen P Bahraoui EM, Traincard F, Fisher R, Plata F. Epitope recognition of conserved HIV envelope sequences by human cytotoxic T lymphocytes. J Immunol. 147:1991;2302.
41. Vitiello A, Sette A, Yuan L, Farness P, Southwood S, Sidney J, Chesnut RW, Grey HM, Livingston B. Comparison of CTL Responses Induced by Peptide or DNA Immunization Implications on Immunogenicity and Immunodominance . Eur J Immunol. 27:1997;671.
42. Bertoletti A, Chisari FV, Penna A, Guilhot S, Galati L, Missale G, Fowler P, Schlicht HJ, Vitiello A, Chesnut RC, et al. Definition of a minimal optimal cytotoxic T-cell epitope within the hepatitis B virus nucleocapsid protein. J Virol. 67:1993;2376.
43. Gotch F, McMichael A, Rothbard J. Recognition of influenza A matrix protein by HLA-A2-restricted cytotoxic T lymphocytes Use of analogues to orientate the matrix peptide in the HLA-A2 binding site . J Exp Med. 168:1988;2045.
44. Van Bleek GM, Nathenson SG. Isolation of an endogenously processed immunodominant viral peptide from the class I H-2Kb molecule [see comments]. Nature. 348:1990;213.
45. Carbone FR, Bevan MJ. Induction of ovalbumin-specific cytotoxic T cells by in vivo peptide immunization. J Exp Med. 169:1989;603.
46. Bonneau RH, Salvucci LA, Johnson DC, Tevethia SS. Epitope specificity of H-2Kb-restricted, HSV-1-, and HSV-2-cross-reactive cytotoxic T lymphocyte clones. Virology. 195:1993;62.
47. Franco MA, Prieto I, Labbe M, Poncet D, Borras Cuesta F Cohen J. An immunodominant cytotoxic T cell epitope on the VP7 rotavirus protein overlaps the H2 signal peptide. J Gen Virol. 74:1993;2579.
48. White HD, Roeder DA, Green WR. An immunodominant Kb-restricted peptide from the p15E transmembrane protein of endogenous ecotropic murine leukemia virus (MuLV) AKR623 that restores susceptibility of a tumor line to anti-AKR/gross MuLV cytotoxic T lymphocytes [published erratum appears in J Virol 1994 May;68(5):3452]. J Virol. 68:1994;897.
49. Franco MA, Lefevre P, Willems P, Tosser G, Lintermanns P, Cohen J. Identification of cytotoxic T cell epitopes on the VP3 and VP6 rotavirus proteins. J Gen Virol. 75:1994;589.
50. b-restricted epitopes. J Immunol. 157:1996;5555.
51. Schumacher TN, De Bruijn ML, Vernie LN, Kast WM, Melief CJ, Neefjes JJ, Ploegh HL. Peptide selection by MHC class I molecules. Nature. 350:1991;703.
52. Kast WM, Roux L, Curren J, Blom HJ, Voordouw AC, Meloen RH, Kolakofsky D, Melief CJ. Protection against lethal Sendai virus infection by in vivo priming of virus-specific cytotoxic T lymphocytes with a free synthetic peptide. Proc Natl Acad Sci U S A. 88:1991;2283.